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Early vascular responses to everolimus-eluting cobalt-chromium stent for
the treatment of ST-elevation acute myocardial infarction: the results of
the MECHANISM-AMI Study 2-week OCT follow-up cohort
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BACKGROUND Several clinical trials have indicated advantages of
everolimus-eluting cobalt chromium stents (EES) for treatment of the
patients with ST-segment elevation myocardial infarction (STEMI)
especially in “very early phase” after implantation. However, vascular
behavior during this period and underlying mechanisms remain
unclear.
METHODS The MECHANISM-AMI study is designed to elucidate early
vascular responses of EES for STEMI patients using optical coherence
tomography (OCT). Patients were prospectively registered in either 2-
week (2W) or 3-month scheduled OCT follow-up cohort. Among them,
2W cohort could be completely analyzed, that is the subject of current
study. In addition to standard OCT parameters, intra-stent thrombus
was quantitatively analyzed in terms of the maximal area and %length
of thrombus (the numbers of cross-section with thrombus  100
divided by total number of cross-sections within the stented
segment).
RESULTS A total of 53 patients (age: 64.011.8 years, male: 84.9%)
were enrolled in this study from 14 sites. A total of 44 patients were
considered available for complete serial OCT analyses due to image
quality, although entire cases completed OCT observation at both
sequences. Average stent length was 23.68.0 mm. Both %uncovered
struts and %malapposed struts signiﬁcantly improved from post-
procedure to 2W follow-up (%uncovered struts: 6119 % vs 2013 %,
p<0.0001, %malapposed struts: 7.29.1 % vs 4.66.0 %, p¼0.006,
respectively). Amount of intra-stent thrombus signiﬁcantly decreased
from post-procedure to 2W follow-up (%length: 3337 % vs 1718 %,
p¼0.003, average maximal area of thrombus: 0.620.74 mm2 vs
0.110.23 mm2, p¼0.0002, respectively). Similarly, number of
dissection ﬂap greater than 200 mm also signiﬁcantly decreased
(0.901.12 vs 0.570.91, p¼0.03, respectively).
CONCLUSIONS The MECHANISM-AMI study 2W cohort ﬁrstly eluci-
dated very early vascular responses following EES implantation in
STEMI patients. Vascular healing processes begin in such a very early
stage, including covered struts of nearly 80%, improvement of strut
apposition and dissection ﬂap size, and a signiﬁcant reduction of
intra-stent thrombus volume within 2 weeks. These meticulous ﬁnd-
ings may potentially explain the underlying mechanisms of safety and
efﬁcacy of EES for STEMI patients, supporting the favorable outcomes
observed in the previous clinical studies.CATEGORIES IMAGING: Intravascular
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Head-to-Head Comparison of Currently Available Coronary Imaging
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BACKGROUND A recent validation study reported an overestimation
in lumen measurements by IVUS compared with optical coherence
tomography (OCT). However, there remains a theoretical concern that
practical differences in image data processing and system conﬁgura-
tions may lead to considerable variability in quantitative precision,
even within the modalities utilizing the same technical principles.
This study aimed to provide head-to-head comparison of the quanti-
tative accuracy among contemporary intravascular imaging systems
currently available in the catheterization laboratory.
METHODS Five coronary models with known lumen diameters (1.51-
5.04 mm) were imaged using 2 OCT and 4 IVUS systems: 1) optical fre-
quency domain imaging (OFDI, FastView, Terumo), 2) Fourier-domain
OCT (FD-OCT, Dragonﬂy JP, St. Jude Medical), 3) 40-MHz mechanical
IVUS (ViewIT, Terumo), 4) 40-MHzmechanical IVUS (OptiCross, Boston
Scientiﬁc), 5) 45-MHz mechanical IVUS (Revolution, Volcano), and 6)
20-MHz solid-state IVUS (Eagle Eye Platinum, Volcano). To standardize
the conditions, all catheter imagings were performed coaxially in a sa-
line-ﬁlled tank at 37C, and IVUS measurements were adjusted to
compensate for the difference in the speed of sound in saline vs. blood.
OFDI and FD-OCT images were obtained under the system setting for
saline ﬂush. In each diameter phantom model, mean lumen diameter
(LD) was obtained at 10 randomly selected cross-sections.
RESULTS Overall, OFDI, FD-OCT, and 40-MHz IVUS (ViewIT) showed
slight overestimation in mean LD (0.020.02, 0.010.02, and
0.020.02 mm, respectively). While another 40-MHz IVUS (OptiCross)
showed a moderate degree of overestimation (0.160.03 mm, P<0.001),
45-MHz IVUS (Revolution) and 20-MHz IVUS (Eagle Eye Platinum)
exhibited underestimation (-0.050.03 mm, P<0.001, and
-0.030.03 mm, P<0.001, respectively). In both OCT and IVUS, the de-
grees of over- or underestimation varied depending on the phantom
diameter (ﬁgure), presumably due to the focus setting of each system.
CONCLUSIONS This validation study warranted clinically acceptable
quantitative precision in all systems. On the other hand, some sys-
tematic variability was observed among the systems and phantom
diameters, which requires attention when using multiple imaging
systems for serial examinations or comparative studies.
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